Infinity Pharmaceuticals Inc (NASDAQ:INFI)

1.86
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
0.93
Today|||52-Week Range
3.84
-8.37%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.006.0M
 
 
Depreciation And Amortization852.0K692.0K692.0K261.0K
 
 
 
 
 
 
Operating ExpensesGross Income-852.0K-692.0K-692.0K--
 
 
 
 
General Expenses22.4M9.8M9.4M13.6M
 
 
 
 
 
Research And Development14.7M4.0M3.9M9.3M
 
 
 
 
 
Total Operating Expenses23.2M10.5M10.1M13.8M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.2M-10.5M-10.1M-7.8M
 
 
 
 
 
Extraordinary Charge0.000.00-6.9M0.00
 
 
Interest Expense On Debt304.0K302.0K300.0K287.0K
 
 
 
 
 
Other Expenses0.000.0018.0K0.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-22.9M-10.5M-17.0M-7.1M
 
 
 
 
 
Net Income-22.9M-10.5M-17.0M-7.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS50.1M50.4M50.5M50.6M
 
 
 
 
 
Shares To Calculate EPS Diluted50.1M50.4M50.5M50.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.46-$0.21-$0.34-$0.14
 
 
 
 
 
EPS Diluted-$0.46-$0.21-$0.34-$0.14